Novo Nordisk has mitigation plans to minimize disruption from port strikes

Danish drugmaker Novo Nordisk (NOVOb.CO) said on Tuesday it has mitigation plans in place to minimize or prevent any disruption to its production due to sea port strikes in the United States.
The maker of popular drugs, Wegovy and Ozempic, plans to ship its products to and from the U.S. via air freight, a company spokesperson said.